A 58 year old nurse has passed away after receiving a weight loss injection, marking the first reported death linked to the ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...

Researchers projected that more than 42,000 deaths could be averted annually, including more than 11,000 among those with type 2 diabetes.

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...

GLP-1 RAs can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight.

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The numbers are based on users or healthcare workers informing the regulator of adverse reactions to the drugs, known as ...

Email [email protected] nurse's death has been linked to her taking a weight-loss drug that was approved for ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

Although chicken contains more protein than eggs, studies show that eggs have a higher digestibility value than chicken. Eggs ...

The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for ...